Managing IP has just published our latest supplements, focusing on Brazil and Mexico.
The Brazil articles discuss life sciences and enforcement.
A new decree regulates Brazil’s Biodiversity Law. Kene Gallois and Danielle Altomari of Daniel Advogados explain why this can represent friendly prospects for innovative life sciences companies
José Carlos Vaz e Dias of Vaz e Dias Advogados & Associados reports on the latest developments to improve the Brazilian IP system
The Mexico articles discuss the Trans-Pacific Partnership, the new opposition system, online marketplaces, patent eligible subject matter and IT as evidence to prove trade mark use.
Jorge Vega, Eduardo Castañeda and Guillermo González of Basham Ringe and Correa explain how the Trans-Pacific Partnership would affect Mexico’s IP system
Laura Collada and Ariadna Galvez of Dumont Bergman Bider & Co discuss Mexico’s experience of the Madrid System since 2013 and point out some flaws in its new opposition system
Fernanda Díaz and Víctor Ramírez of Olivares discuss the role and responsibilities of online intermediaries in connection with IP rights in Mexico
Héctor Chagoya and Claudia Campos of Becerril Coca & Becerril discuss the features of the Mexican patent system under a new environment for human creativity recognition, and analyse statutory provisions given the scarcity of administrative or judiciary precedents available for interpreting Mexican law
Enrique Romano Barragán of Goodrich discusses the importance of information technology as evidence to prove trade mark use in cancellation actions on grounds of lack of use according to Mexican law
Managing IP has also this year published supplements on Asia Pacific, Canada, Europe, India, Americas, China and Turkey. You can view them all here.
The material on this site is for law firms, companies and other IP specialists. It is for information only. Please read our Terms and Conditions and Privacy Notice before using the site. All material subject to strictly enforced copyright laws.
© 2020 Euromoney Institutional Investor PLC. For help please see our FAQs.